Zacks Investment ResearchTue, 02 Jun 2026 15:25:17 GMTAGIO Secures Global Rights to Late-Stage Rare Blood Disorder CandidateAGIO+2.55%
Seeking AlphaMon, 01 Jun 2026 20:24:07 GMTAgios Pharmaceuticals, Inc. (AGIO) Discusses Global License Agreement for Cevidoplenib and Strategic Expansion in Rare Hematology TranscriptAGIO+2.55%
Zacks Investment ResearchMon, 01 Jun 2026 14:46:40 GMTAGIO Halts Tebapivat Development in Myelodysplastic SyndromesAGIO+2.55%
Zacks Investment ResearchFri, 29 May 2026 16:32:12 GMTWhy Is Agios Pharmaceuticals (AGIO) Up 8.6% Since Last Earnings Report?AGIO+2.55%
Zacks Investment ResearchMon, 25 May 2026 16:11:06 GMTAGIO's Pyrukynd Gets Approval for Thalassemia in EuropeAGIO+2.55%
MarketBeatTue, 19 May 2026 17:04:49 GMTAgios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing AdvancesAGIO+2.55%
Zacks Investment ResearchWed, 13 May 2026 16:25:37 GMTAgios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell DiseaseAGIO+2.55%
Zacks Investment ResearchThu, 30 Apr 2026 19:35:15 GMTAGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug MomentumAGIO+2.55%
Seeking AlphaWed, 29 Apr 2026 19:01:49 GMTAgios Pharmaceuticals, Inc. (AGIO) Q1 2026 Earnings Call TranscriptAGIO+2.55%
Zacks Investment ResearchWed, 29 Apr 2026 12:46:33 GMTAgios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue EstimatesAGIO+2.55%
Zacks Investment ResearchWed, 22 Apr 2026 15:01:52 GMTEarnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to DeclineAGIO+2.55%
Zacks Investment ResearchTue, 21 Apr 2026 14:36:10 GMTAgios Stock Sinks 23% as NVO's PKR Activator Meets Goal in SCD StudyAGIO+2.55%
The Motley FoolMon, 20 Apr 2026 16:19:21 GMTHere's Why Agios Pharmaceuticals Crashed 23% TodayAGIO+2.55%
Zacks Investment ResearchWed, 01 Apr 2026 16:16:16 GMTAGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCDAGIO+2.55%
Zacks Investment ResearchWed, 01 Apr 2026 10:50:37 GMTAgios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?AGIO+2.55%
The Motley FoolTue, 31 Mar 2026 16:08:31 GMTWhy Agios Pharmaceuticals Stock Is Up More Than 21% TodayAGIO+2.55%
The Motley FoolTue, 31 Mar 2026 16:03:59 GMTInsider Sells AGIO Shares Worth $82,000 -- But Context Is EverythingAGIO+2.55%
Investors Business DailyTue, 31 Mar 2026 13:36:50 GMTAgios Pharma Rallies On A Surprise FDA Move In Sickle Cell DiseaseAGIO+2.55%
Zacks Investment ResearchWed, 18 Mar 2026 14:46:21 GMTAgios Pharmaceuticals Stock Declines 23% in 6 Months: Here's WhyAGIO+2.55%
